Insulin and IGF1 receptors in human cardiac microvascular endothelial cells: Metabolic, mitogenic and anti-inflammatory effects

Journal of Endocrinology

Volumn 215, Issue 1, 2012, Pages 89-96

  Bäck, Karolina ^a   Islam, Rakibul ^a   Johansson, Git S ^a   Chisalita, Simona I ^a   Arnqvist, Hans J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; INSULIN RECEPTOR; RECEPTOR ANTIBODY; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARDIAC MICROVASCULAR ENDOTHELIAL CELL; DIABETES MELLITUS; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INFLAMMATION; MICROVASCULAR ENDOTHELIAL CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MICROVESSELS; MYOCARDIUM; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN;

EID: 84869234724     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0261     Document Type: Article

References (36)

1. Abbas A, Imrie H, Viswambharan H, Sukumar P, Rajwani A, Cubbon RM, Gage M, Smith J, Galloway S, Yuldeshava N et al. 2011 The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium. Diabetes 60 2169-2178.
2. Asghar O, Al-Sunni A, Khavandi K, Khavandi A, Withers S, Greenstein A, Heagerty AM & Malik RA. 2009 Diabetic cardiomyopathy. Clinical Science 116 741-760.
3. Bäck K & Arnqvist HJ. 2009 Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. Growth Hormone & IGF Research 19 101-111.
4. Balaram SK, Agrawal DK, Allen RT, Kuszynski CA & Edwards JD. 1997 Cell adhesion molecules and insulin-like growth factor-1 in vascular disease. Journal of Vascular Surgery 25 866-876.
5. Bereket A, Lang CH &Wilson TA. 1999 Alterations in the growth hormone- insulin-like growth factor axis in insulin dependent diabetes mellitus. Hormone and Metabolic Research 31 172-181.
6. Carey PE, Halliday J, Snaar JE, Morris PG & Taylor R. 2003 Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects. American Journal of Physiology. Endocrinology and Metabolism 284 E688-E694.
7. Chisalita SI & Arnqvist HJ. 2004 Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. American Journal of Physiology. Endocrinology and Metabolism 286 E896-E901.
8. Chisalita SI, Nitert MD & Arnqvist HJ. 2006 Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells. Growth Hormone & IGF Research 16 258-266.
9. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS et al. 1998 Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 3527-3561.
10. Dandona P, Chaudhuri A, Ghanim H & Mohanty P. 2009 Insulin as an antiinflammatory and antiatherogenic modulator. Journal of the American College of Cardiology 53 S14-S20.
11. Delafontaine P, Song YH & Li Y. 2004 Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arteriosclerosis, Thrombosis, and Vascular Biology 24 435-444.
12. Dupont J & LeRoith D. 2001 Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Hormone Research 55 (Suppl 2) 22-26.
13. Ewart MA, Kohlhaas CF & Salt IP. 2008 Inhibition of tumor necrosis factor a-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase. Arteriosclerosis, Thrombosis, and Vascular Biology 28 2255-2257.
14. Frystyk J. 2004 Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Hormone & IGF Research 14 337-375.
15. Hedman CA, Frystyk J, Lindstrom T, Chen JW, Flyvbjerg A, Orskov H & Arnqvist HJ. 2004 Residual b-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 89 6305-6309.
16. Johansson GS, Chisalita SI & Arnqvist HJ. 2008 Human microvascular endothelial cells are sensitive to IGF-I but resistant to insulin at the receptor level. Molecular and Cellular Endocrinology 296 58-63.
17. Kim JA, Montagnani M, Koh KK & Quon MJ. 2006 Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113 1888-1904.
18. Leto D & Saltiel AR. 2012 Regulation of glucose transport by insulin: traffic control of GLUT4. Nature Reviews. Molecular Cell Biology 13 383-396.
19. Madonna R, Pandolfi A, Massaro M, Consoli A & De Caterina R. 2004 Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 47 532-536.
20. Mako V, Czucz J, Weiszhar Z, Herczenik E, Matko J, Prohaszka Z & Cervenak L. 2010 Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1b, TNF-a, and LPS. Cytometry. Part A 77 962-970.
21. MontagnaniM, Golovchenko I, KimI, KohGY, GoalstoneML, MundhekarAN, Johansen M, Kucik DF, Quon MJ & Draznin B. 2002 Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. Journal of Biological Chemistry 277 1794-1799.
22. Moxham CP, Duronio V & Jacobs S. 1989 Insulin-like growth factor I receptor b-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. Journal of Biological Chemistry 264 13238-13244.
23. Nitert MD, Chisalita SI, Olsson K, Bornfeldt KE & Arnqvist HJ. 2005 IGF-I/insulin hybrid receptors in human endothelial cells. Molecular and Cellular Endocrinology 229 31-37.
24. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R & Orchard TJ. 2006 The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55 1463-1469.
25. Picchi A, Capobianco S, Qiu T, Focardi M, Zou X, Cao JM & Zhang C. 2010 Coronary microvascular dysfunction in diabetes mellitus: a review. World Journal of Cardiology 2 377-390.
26. Siddle K, Urso B, Niesler CA, Cope DL, Molina L, Surinya KH & Soos MA. 2001 Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. Biochemical Society Transactions 29 513-525.
27. Slaaby R, Schaffer L, Lautrup-Larsen I, Andersen AS, Shaw AC, Mathiasen IS & Brandt J. 2006 Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. Journal of Biological Chemistry 281 25869-25874.
28. Soos MA, Field CE & Siddle K. 1993 Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochemical Journal 290 419-426.
29. Strindhall J, Lundblad A & Pahlsson P. 1997 Interferon-g enhancement of E-selectin expression on endothelial cells is inhibited by monensin. Scandinavian Journal of Immunology 46 338-343.
30. Tarquini R, Lazzeri C, Pala L, Rotella CM & Gensini GF. 2010 The diabetic cardiomyopathy. Acta Diabetologica 48 173-181.
31. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC & Goligorsky MS. 1994 Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney International 45 598-604.
32. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UDPDS 33). Lancet 352 837-853.
33. Wang GF, Wu SY, Xu W, Jin H, Zhu ZG, Li ZH, Tian YX, Zhang JJ, Rao JJ & Wu SG. 2010 Geniposide inhibits high glucose-induced cell adhesion through the NF-kappaB signaling pathway in human umbilical vein endothelial cells. Acta Pharmacologica Sinica 31 953-962.
34. Ward CW, Lawrence MC, Streltsov VA, Adams TE & McKern NM. 2007 The insulin and EGF receptor structures: new insights into ligand-induced receptor activation. Trends in Biochemical Sciences 32 129-137.
35. Werner H, Weinstein D & Bentov I. 2008 Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways. Archives of Physiology and Biochemistry 114 17-22.
36. Zheng HT, Zhou LN, Huang CJ, Hua X, Jian R, Su BH & Fang F. 2008 Selenium inhibits high glucose- and high insulin-induced adhesion molecule expression in vascular endothelial cells. Archives of Medical Research 39 373-379.